Contineum Therapeutics, Inc.(CTNM) - 2025 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) 3565 General Atomics Court, Suite 200 San Diego, California 92121 (Address of principal executive offices) (Zip Code) Commission File Number: 001-42001 Contineum Therapeutics, Inc. (Exact name of registrant as specified in its charter) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 (State or other jurisdict ...